MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells

MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3

(2014) Huijuan Wu et al.   ANTI-CANCER DRUGS

Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy

(2014) Juntao Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line

(2014) Radosław Januchowski et al.   Biomed Research International

Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells

(2013) Zhiqiang Han et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells

(2013) Xiao-Shuai Ren et al.   CANCER LETTERS

miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells

(2013) Jianghong Hu et al.   DIGESTIVE DISEASES AND SCIENCES

Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway

(2012) Klaus Geissler et al.   ANNALS OF HEMATOLOGY

MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins

(2012) Hong Chen et al.   CANCER LETTERS

Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling

(2012) Y.-P. Liu et al.   CANCER RESEARCH

Report of incidence and mortality in China Cancer Registries, 2008

(2012) Wan-qing Chen et al.   Chinese Journal of Cancer Research

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

(2012) Xin Fu et al.   FEBS LETTERS

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

(2012) S. M. McAuliffe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells

(2011) Ran Qiang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance

(2011) G. Ye et al.   JOURNAL OF CELL SCIENCE

Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells

(2011) Xiaohong Zhao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1

(2011) Fanfei Kong et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2

(2011) Wei Zhu et al.   MEDICAL ONCOLOGY

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer

(2011) Tony Bou Kheir et al.   Molecular Cancer

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

(2011) Michael P. Stany et al.   PLoS One

MicroRNA-449a Overexpression, Reduced NOTCH1 Signals and Scarce Goblet Cells Characterize the Small Intestine of Celiac Patients

(2011) Marina Capuano et al.   PLoS One

E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis

(2009) M Lizé et al.   CELL DEATH AND DIFFERENTIATION

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

(2009) E J Noonan et al.   ONCOGENE

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

(2008) H. Yang et al.   CANCER RESEARCH